I have been in contact with Dr. Miriam J. de Jonge M.D., who herself was floxed. She has asked me to post a comprehensive “Dear Colleague” letter that she wrote to inform fellow doctors of fluoroquinolone (FQ) toxicity. The letter is very well documented and can be distributed to doctors to inform and/or initiate patient/doctor discussions regarding FQ toxicity. This resource is available to the FQ community. There is an email listed in the letter for doctors to contact Dr. de Jonge for questions. At this time Dr. de Jonge is requesting that no patient contact her regarding medical questions or information.
New Dear Colleague Letter
About the Author: Admin
David experienced an adverse event to the the fluoroquinolone Levaquin in 2007 at age 46. Prior to, he was a healthy law enforcement official. Now, disabled with drug induced mitochondrial disease/dysfunction, he is an FQ patient safety advocate, citizen scientist, FQ researcher, author, and commentator. He has contributed to case studies and published academic papers on the FQ’s in the BMJ, European Journal of Medicine, The Journal of Community and Supportive Oncology, Oxford Academic Clinical infectious Diseases, and contributed data to many more outlets.